FindMyKOL
Clinical trialNCT01497873CompletedPhase 2Interventional

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

SponsorChong Kun Dang PharmaceuticalEnrollment164Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the efficacy and safety of Belotecan administered 5 days every 3 weeks in comparison to Topotecan in Patients with relapsed small cell lung cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Chungbuk University Hospital

    Daegu, South Korea

  • Keimyung University Dongsan Center

    Daegu, South Korea

  • National Cancer Center

    Goyang, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Cha Bundang Medical Center

    Seoul, South Korea

  • Chung-Ang University Hospital

    Seoul, South Korea

  • Kyung Hee University Medical Hospital

    Seoul, South Korea

  • Seoul National University Boramae Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Seoul St. Marys Hospital

    Seoul, South Korea

  • Seoul Veterans Hospital

    Seoul, South Korea

  • Yonsei Cancer Center

    Seoul, South Korea

  • Ajou University Hospital

    Suwon, South Korea

  • St. Vincents Hospital

    Suwon, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BelotecanTopotecan →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2010
Primary completion
31 Dec 2017
Completion
31 Mar 2018
Last update posted
27 Dec 2018
Registered enrollment
164
Registry id
NCT01497873
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.